Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 4, 2016, Pages 757-764

  Caselli, Chiara ^a   Prontera, Concetta ^b   Liga, Riccardo ^c   De Graaf, Michiel A ^d   Gaemperli, Oliver ^e   Lorenzoni, Valentina ^f   Ragusa, Rosetta ^f   Marinelli, Martina ^a   Del Ry, Silvia ^a   Rovai, Daniele ^a   Giannessi, Daniela ^a   Aguade Bruix, Santiago ^g   Clemente, Alberto ^b,f   Bax, Jeroen J ^d   Lombardi, Massimo ^b   Sicari, Rosa ^a   Zamorano, José ^h   Scholte, Arthur J ^d   Kaufmann, Philipp A ^e   Knuuti, Juhani ⁱ   Underwood, S Richard ^j   Clerico, Aldo ^b   Neglia, Danilo ^a,b   more..

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b Fondazione Toscana G Monasterio   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f SCUOLA SUPERIORE SANT ANNA   (Italy)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h UNIVERSITY OF ALCALÁ   (Spain)

ⁱ TURKU UNIVERSITY HOSPITAL   (Finland)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

coronary artery disease; hs cardiac troponin T; myocardial ischemia; NT proBNP; stable angina

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH SENSITIVITY TROPONIN T; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; TROPONIN T; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TNNT2 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM SCORE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; ANGINA, STABLE; BLOOD; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EUROPE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROCEDURES; SEVERITY OF ILLNESS INDEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL MODEL; STRESS ECHOCARDIOGRAPHY;

ANGINA, STABLE; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY, STRESS; EUROPE; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TROPONIN T;

EID: 84957928317     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306818     Document Type: Article

References (27)

1. Task Force Members. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
2. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction; ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551-2567.
3. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361:2538-2547. doi: 10.1056/NEJMoa0805299.
4. Ndrepepa G, Braun S, Mehilli J, et al. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J. 2011;161:68-75. doi: 10.1016/j. ahj.2010.09.018.
5. Ndrepepa G, Braun S, Schulz S, Fusaro M, Keta D, Pache J, Seyfarth M, Mehilli J, Schömig A, Kastrati A. Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina. Eur J Clin Invest. 2011;41:1054-1062. doi: 10.1111/j.1365-2362.2011.02500.x.
6. Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005;352:666-675. doi: 10.1056/NEJMoa042330.
7. Ndrepepa G, Braun S, Niemöller K, Mehilli J, von Beckerath N, von Beckerath O, Vogt W, Schömig A, Kastrati A. Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation. 2005;112:2102-2107. doi: 10.1161/ CIRCULATIONAHA.105.550715.
8. Neglia D, Rovai D, Caselli C, et al; EVINCI Study Investigators. Detection of significant coronary artery disease by noninvasive anatomical and functional imaging. Circ Cardiovasc Imaging. 2015;8:pii: e002179. doi: 10.1161/CIRCIMAGING.114.002179.
9. Franzini M, Lorenzoni V, Masotti S, et al. The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: a multicenter study in Italy. Clin Chim Acta. 2015;438:376-381. doi: 10.1016/j.cca.2014.09.010.
10. Wu AH, Christenson RH. Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care. Clin Biochem. 2013;46:969-978. doi: 10.1016/j.clinbiochem.2013.04.013.
11. Laufer EM, Mingels AM, Winkens MH, Joosen IA, Schellings MW, Leiner T, Wildberger JE, Narula J, Van Dieijen-Visser MP, Hofstra L. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol. 2010;30:1269-1275. doi: 10.1161/ATVBAHA.109.200394.
12. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011;57:2406-2408. doi: 10.1016/j.jacc.2011.01.029.
13. Turer AT, Addo TA, Martin JL, Sabatine MS, Lewis GD, Gerszten RE, Keeley EC, Cigarroa JE, Lange RA, Hillis LD, de Lemos JA. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol. 2011;57:2398-2405. doi: 10.1016/j. jacc.2010.11.066.
14. Heusch G, Schulz R, Haude M, Erbel R. Coronary microembolization. J Mol Cell Cardiol. 2004;37:23-31. doi: 10.1016/j.yjmcc.2004.04.011.
15. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, Humpert PM, Giannitsis E, Katus HA. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart. 2011;97:823-831. doi: 10.1136/ hrt.2010.193201.
16. Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van De Sand A, Konietzka I, Büchert A, Krüger A, Schulz R, Heusch G. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res. 2002;90:807-813.
17. Hickman PE, Potter JM, Aroney C, Koerbin G, Southcott E, Wu AH, Roberts MS. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta. 2010;411:318-323. doi: 10.1016/j.cca.2009.12.009.
18. American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147-e239.
19. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Müller KD, Berkovitsch A, Mitrovic V, Hamm C. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J. 2004;148:612-620. doi: 10.1016/j.ahj.2004.04.021.
20. Peer A, Falkensammer G, Alber H, Kroiss A, Griesmacher A, Ulmer H, Pachinger O, Mair J. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease. Heart. 2009;95:297-303. doi: 10.1136/hrt.2008.145425.
21. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M, Hall C, McCabe CH, Braunwald E. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol. 2004;44:1988-1995. doi: 10.1016/j.jacc.2004.07.057.
22. Casals G, Ros J, Sionis A, Davidson MM, Morales-Ruiz M, Jiménez W. Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes. Am J Physiol Heart Circ Physiol. 2009;297:H550-H555. doi: 10.1152/ajpheart.00250.2009.
23. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103-114. doi: 10.1161/CIRCULATIONAHA.107.702993.
24. Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP; TIME-CHF Investigators. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Eur J Heart Fail. 2013;15:1148-1156. doi: 10.1093/eurjhf/hft076.
25. Jhund PS, Claggett BL, Voors AA, Zile MR, Packer M, Pieske BM, Kraigher-Krainer E, Shah AM, Prescott MF, Shi V, Lefkowitz M, McMurray JJ, Solomon SD; PARAMOUNT Investigators. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696. Circ Heart Fail. 2014;7:953-959. doi: 10.1161/ CIRCHEARTFAILURE.114.001427.
26. Giannoni A, Giovannini S, Clerico A. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal? Clin Chem Lab Med. 2009;47:1167-1177. doi: 10.1515/CCLM.2009.320.
27. Clerico A, Passino C, Franzini M, Emdin M. Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. Clin Chim Acta. 2015;443:17-24. doi: 10.1016/j.cca.2014.06.003.